GLAXOSMITHKLINE EXPORT LIMITED

Active London

Wholesale of pharmaceutical goods

35 employees website.com
Life sciences and medical technology Wholesale of pharmaceutical goods
G

GLAXOSMITHKLINE EXPORT LIMITED

Wholesale of pharmaceutical goods

Founded 18 Oct 1989 Active London, United Kingdom 35 employees website.com
Life sciences and medical technology Wholesale of pharmaceutical goods

Previous Company Names

GLAXO WELLCOME EXPORT LIMITED 1 Jul 1995 — 20 Dec 2001
GLAXO EXPORT LIMITED 1 Dec 1989 — 1 Jul 1995
STRONGHOT LIMITED 18 Oct 1989 — 1 Dec 1989
Accounts Submitted 7 Jul 2025 Next due 30 Sept 2026 5 months remaining
Confirmation Submitted 31 Jul 2025 Next due 14 Aug 2026 3 months remaining
Net assets £261M £12M 2024 year on year
Total assets £340M £7M 2024 year on year
Total Liabilities £79M £5M 2024 year on year
Charges None No charges registered

Contact & Details

Contact

Registered Address

79 New Oxford Street London WC1A 1DG United Kingdom

Telephone

0800 000 0000

Email

info@example.com

Website

www.example.com

Full company profile for GLAXOSMITHKLINE EXPORT LIMITED (02433585), an active life sciences and medical technology company based in London, United Kingdom. Incorporated 18 Oct 1989. Wholesale of pharmaceutical goods. View financials, directors, shareholders, and filings.

Business Summary

This company specializes in providing innovative solutions and services across multiple sectors.

Products & Services

consulting software analytics integration

Reports

Credit Report

In-depth credit score, financial analysis, risk assessment and company intelligence.

Financials

Financials

Period 1 Jan → 31 Dec 2024
Type Total Exemption Full
Next accounts 31 December 2025
Due by 30 September 2026 9 months

Balance Sheet & P&L (2014–2024)

Cash in Bank

£77.73M

Decreased by £3.65M (-4%)

Net Assets

£260.99M

Increased by £11.55M (+5%)

Total Liabilities

£79.12M

Decreased by £4.56M (-5%)

Turnover

£628.06M

Decreased by £13.67M (-2%)

Employees

35

Decreased by 193 (-85%)

Debt Ratio

23%

Decreased by 2 (-8%)

Financial History

Revenue, profit, EBITDA and key financial figures

2024
Dec Year End
2023
Dec Year End
P&L
Revenue
£142.3M
£128.7M
Gross Profit
£48.2M
£43.1M
Operating Profit
£22.4M
£19.8M
Net Profit
£18.1M
£15.9M
EBITDA
£31.5M
£28.2M
Assets
Cash
£24.7M
£21.3M
Total Assets
£89.4M
£82.1M
Liabilities
Total Liabilities
£45.2M
£41.8M
Key Metrics
Employees
1,247
1,156
Latest Revenue
£142.3M
Latest EBITDA
£31.5M
Cash Position
£24.7M

Funding

Fundraising & Grants

No fundraising or grants recorded

Investors (0)

No investor information available

Officers

Officers

0 active 3 resigned
Status

No officers found

No officers found

Shareholders

Shareholders (1)

Glaxo Group Limited
100.0%

Persons with Significant Control

Persons with Significant Control (1)

1 Active

Glaxo Group Limited

United Kingdom

Active
Notified 6 Apr 2016
Nature of Control
  • Ownership Of Shares 75 To 100 Percent,voting Rights 75 To 100 Percent,right To Appoint And Remove Directors

Group Structure

Group Structure

GSK PLC united kingdom
GLAXO GROUP LIMITED united kingdom
GLAXOSMITHKLINE EXPORT LIMITED Current Company

Charges

Charges

No charges registered

Properties

Properties

0 total

No related properties

Documents

Company Filings

DateCategoryDescriptionDocument
12 Nov 2025OfficersTermination of Michael Sean Reilly as director on 2025-11-01
12 Nov 2025OfficersAppointment of Dr James Bringloe as director on 2025-11-01
3 Sept 2025OfficersTermination of Emma Hunter as director on 2025-09-01
31 Jul 2025Confirmation StatementConfirmation statement made on 2025-07-31 with no updates
7 Jul 2025AccountsAnnual accounts made up to 2024-12-31
12 Nov 2025 Officers

Termination of Michael Sean Reilly as director on 2025-11-01

12 Nov 2025 Officers

Appointment of Dr James Bringloe as director on 2025-11-01

3 Sept 2025 Officers

Termination of Emma Hunter as director on 2025-09-01

31 Jul 2025 Confirmation Statement

Confirmation statement made on 2025-07-31 with no updates

7 Jul 2025 Accounts

Annual accounts made up to 2024-12-31

Recent Activity

Latest Activity

Termination of Michael Sean Reilly as director on 2025-11-01

5 months ago on 12 Nov 2025

Appointment of Dr James Bringloe as director on 2025-11-01

5 months ago on 12 Nov 2025

Termination of Emma Hunter as director on 2025-09-01

7 months ago on 3 Sept 2025

Confirmation statement made on 2025-07-31 with no updates

8 months ago on 31 Jul 2025

Annual accounts made up to 2024-12-31

9 months ago on 7 Jul 2025